Quality assurance for antimicrobial susceptibility testing of<i>Neisseria gonorrhoeae</i>in Latin American and Caribbean countries, 2013–2015

Simple item page
dc.contributor.authorPam Sawatzky
dc.contributor.authorIrene Martín
dc.contributor.authorPatricia Galarza
dc.contributor.authorMarıa Elena Trigoso Carvallo
dc.contributor.authorPamela Araya Rodriguez
dc.contributor.authorOlga Marina Sanabria Cruz
dc.contributor.authorAlina Llop Hernández
dc.contributor.authorMario Fabian Martinez
dc.contributor.authorGraciela Borthagaray
dc.contributor.authorDaisy Payares
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T14:52:37Z
dc.date.available2026-03-22T14:52:37Z
dc.date.issued2018
dc.descriptionCitaciones: 8
dc.description.abstractThe participating laboratories had acceptable results, similar to other international quality assurance programmes. It is important to ensure continuation of the International Gonococcal Antimicrobial Susceptibility Quality Control Comparison Programme to ensure that participants can identify and correct any problems in antimicrobial susceptibility testing for <i>N. gonorrhoeae</i> as they arise and continue to generate reproducible and reliable data.
dc.identifier.doi10.1136/sextrans-2017-053502
dc.identifier.urihttps://doi.org/10.1136/sextrans-2017-053502
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/49068
dc.language.isoen
dc.publisherBMJ
dc.relation.ispartofSexually Transmitted Infections
dc.sourcePublic Health Agency of Canada
dc.subjectCefixime
dc.subjectNeisseria gonorrhoeae
dc.subjectMedicine
dc.subjectEtest
dc.subjectPenicillin
dc.subjectSpectinomycin
dc.subjectMicrobiology
dc.subjectCiprofloxacin
dc.subjectAntimicrobial
dc.subjectTetracycline
dc.titleQuality assurance for antimicrobial susceptibility testing of<i>Neisseria gonorrhoeae</i>in Latin American and Caribbean countries, 2013–2015
dc.typearticle

Files

Collections

Artículo Científico Publicado